Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Kikuchi-Fujimoto disease. (Histiocytic necrotizing lymphadenitis): The case report of a rare disease.

Sujan Narayan Agrawal.




Abstract
Cited by 0 Articles

Introduction: The Kikuchi-Fujimoto disease (KFD), also called histiocytic necrotizing lymphadenitis, is a benign, self-limiting disease of lymph nodes. It is a disease of unknown aetiology, and it causes cervical lymphadenitis. It predominantly affects young women. It closely mimics an infective, neoplastic or autoimmune disorder. Case report: Here, we present a case of a 28-year female having enlarged cervical and axillary lymph nodes. She had a fever, rash, and arthralgia. Fine needle aspiration cytology (FNAC) was reported reactive lymphadenitis, and the patient started on antibiotics. The response was unsatisfactory, so further investigations were done, including workup for tuberculosis and lymphomas. Histopathology and immunohistochemistry suggested the diagnosis of Kikuchi's disease. She responded well to symptomatic treatment. Conclusion: The paper highlights a rare disease entity, i.e., Kikuchi-Fujimoto disease. The presentation is misleading; unless the clinician knows this disease, it involves unnecessary investigations and treatment.

Key words: Kikuchi-Fujimoto disease, Histiocytic Necrotizing Lymphadenitis, Systemic Lupus Erythematosus (SLE), Immunohistochemistry






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.